Crispr Therapeutics Ag (CRSP)

P/OCF Ratio

-13.03×

TTM · Retrieved:

CRSP logo

CRSP P/OCF Ratio

Current (TTM)-13.03×
CRSP Quarterly P/OCF Ratio (-31.69× → -63.04×)
High-resolution chart · PNG

CRSP p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-63.042×
-41.9585×
-50.9511×
-69.9187×
-37.1889×
-54.2105×
-67.2358×
-37.4542×
-47.9325×
50.8124×
-51.924×
-90.4407×
-33.3234×
404.4278×
-28.0988×
-48.3977×
-33.1474×
-35.7845×
-67.5111×
-104.7879×
15.2113×
-90.7159×
-132.2424×
-77.3748×
-153.7967×
-49.2872×
1,035.4543×
16.8449×
-69.7488×
-42.2229×
-51.8672×
-100.5098×
-109.1594×
-92.4302×
-72.578×
-45.1465×
-40.0083×
-36.9398×
-41.446×
-45.6216×
-41.1681×
-41.2229×
5.9824×
-77.6974×
-29.0065×
-31.6868×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.